3onedata Co., Ltd. (688618.SH) achieved a net profit of 33.8968 million yuan in the fiscal year 2024, a decrease of 69% compared to the previous year.
Sanwang Communications (688618.SH) discloses its preliminary financial results for the year 2024, with a total operating income of 3.57 billion...
3onedata Co., Ltd. (688618.SH) disclosed its performance report for the year 2024, with the company achieving a total operating revenue of 357 million yuan, a year-on-year decrease of 18.79%; achieving a net profit attributable to the owners of the parent company of 33.8968 million yuan, a year-on-year decrease of 69%; achieving a net profit attributable to the owners of the parent company after deducting non-recurring gains and losses of 21.6924 million yuan, a year-on-year decrease of 77.06%. Basic earnings per share were 0.31 yuan.
During the reporting period, the company's solution-based business revenue decreased by approximately 56.55 million yuan, a year-on-year decrease of approximately 87.37%, and overseas business revenue decreased by approximately 21.47 million yuan, a year-on-year decrease of approximately 46%, leading to an overall decrease in net profit.
Related Articles

HK Stock Market Move | BLACK SESAME(02533) opens higher by more than 5%, Huashan A2000 chip passes US review.

CITIC SEC: The tourism market starts off strong in 2026, and duty-free shopping on outlying islands experiences a robust recovery.

Guotai Haitong: raised the target price of DUALITYBIO-B (09606) to 455.56 Hong Kong dollars and maintained a buy rating.
HK Stock Market Move | BLACK SESAME(02533) opens higher by more than 5%, Huashan A2000 chip passes US review.

CITIC SEC: The tourism market starts off strong in 2026, and duty-free shopping on outlying islands experiences a robust recovery.

Guotai Haitong: raised the target price of DUALITYBIO-B (09606) to 455.56 Hong Kong dollars and maintained a buy rating.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


